Quartz Partners’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.14M Buy
21,128
+3,395
+19% +$352K 0.7% 41
2026
Q1
$1.72M Buy
17,733
+1,057
+6% +$108K 0.66% 44
2025
Q4
$1.77M Buy
16,676
+1,227
+8% +$142K 0.66% 40
2025
Q3
$1.96M Buy
15,449
+3,540
+30% +$421K 0.71% 37
2025
Q2
$1.46M Buy
11,909
+74
+0.6% +$8.45K 0.67% 43
2025
Q1
$1.2M Sell
11,835
-4,519
-28% -$441K 0.73% 40
2024
Q4
$1.51M Buy
16,354
+442
+3% +$43.4K 0.92% 28
2024
Q3
$1.54M Buy
+15,912
New +$1.43M 0.96% 29

Other funds holding EHC

Quartz Partners's EHC Position: Q2 2026 in Review

Quartz Partners increased its Encompass Health (EHC) stake by 19% in Q2 2026, buying an estimated $352K and bringing the position to 21,128 shares worth $2.14M. The position accounts for 0.7% of the portfolio, ranked #41.

Quartz Partners first reported a position in EHC in Q3 2024 and has held it in 8 quarters since. 598 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Quartz Partners held 21,128 shares of Encompass Health worth $2.14M as of Q2 2026.
  • Quartz Partners bought 3,395 Encompass Health shares in Q2 2026, an estimated $352K.
  • Encompass Health made up 0.7% of Quartz Partners's portfolio in Q2 2026, its #41 holding.
  • Quartz Partners first reported a position in Encompass Health in Q3 2024 and has held it in 8 quarters since.
  • 598 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Quartz Partners's 13F filing for Q2 2026, filed 10 Aug 2026.